Exposing retinal pigment epithelium cells in mouse models to amyloid-beta resulted in retinal pathologies similar to those seen in human age-related macular degeneration.
A new study reports amyloid beta proteins are able to accumulate in the retina and damage it, which may result in age related macular degeneration in older people.
Following a Mediterranean diet with greater adherence was linked to the lowest risk of cognitive impairment. High fish and vegetable consumption appeared to have the greatest protective effect against cognitive decline.
Eating a handful of dried goji berries five times a week may help delay or even prevent the onset of age-related macular degeneration. Over a 90 day period, those who ate goji berries had an increase in protective pigments in their eyes.
According to a new study, patients with high risk macular degeneration showed improvement when they were treated with a high dose statin.
Researchers link microscopic spheres of calcium phosphate to the development of AMD.
Researchers investigate the link between cognitive function and levels of a vital eye pigment linked to diet.
A new study reveals a considerable link between three common eye diseases and an increased risk of developing Alzheimer's disease. Researchers believe their findings could help physicians better detect those at risk of developing dementia.
A new study reports the dietary supplement Omega 3 does not slow cognitive decline in older people, especially if they already have preexisting cognitive problems.
A new study reports L-DOPA may be able to delay or prevent macular degeneration associated with aging.
Cognitive tests that rely on vision-dependent tasks may skew results for up to 25% of adults over 50 with undiagnosed visual problems such as AMD and cataracts. This may lead to a misdiagnosis of mild cognitive impairment in older adults.
Fluoxetine, the antidepressant commonly known as Prozac, may be beneficial for the treatment of age-related macular degeneration. Researchers found Prozac significantly slowed the rate at which people over 50 developed AMD.
